Clinical Trials Browser

Phase 1 × Advanced Cancer × ralimetinib × Clear all

NCT01393990 2020-03-24

A Study of LY2228820 in Participants With Advanced Cancer

Phase 1 Completed

89 enrolled 30 charts

Advanced Cancer